Covid-19 show medicines

‘Transplant’ Renewed For Season 2 At NBC

Reading now: 607
deadline.com

NBC has ordered a second season of hit Canadian medical drama Transplant. The network acquired the drama series in May, weeks into the COVID-19 production shutdown, and it has been a huge success ratings-wise.In its first season on NBC, Transplant has averaged a 0.7 rating in adults 18-49 and 5.7 million viewers overall in Live+7, with the premiere having grown to a 1.8 in 18-49 with digital and linear viewing.

The series has scored as one of television’s most time-shifted shows through its NBC run, with each of its first seven original telecasts ranking as the No.

1 drama of the week in Live+3. In linear and digital viewing to date, Transplant is averaging 7.7 million total viewers, more than doubling its 3.5 million in L+Same Day.In its

Read more on deadline.com
The website starsalert.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA